Skip to content

yoga for diabetic autonomic neuropathy

Comparative assessment of yoga-based intervention vs. American Diabetes Association exercise regime along with standard of care for autonomic Neuropathy in diabetes mellitus: An Exploratory clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/039068
Enrollment
70
Registered
2021-12-30
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E134- Other specified diabetes mellituswith neurological complications

Interventions

Intervention1: yoga: 1 Starting prayer: Asatoma Sat Gamaya 3 min 2 Asana Preparatory Sukshma Vyayamas and Shithilikarana Practices Tadasana Tiryak Tadasana Katichakrasana Bhujangasana Pashchimottana

Sponsors

Aiims Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Type two diabetes mellitus with diagnosed Autonomic Neuropathy. Age Between 35 - 60 years.

Exclusion criteria

Exclusion criteria: ï?? Patients opting for treatment not in compliance with randomization sequence ï?? Patients on insulin ï?? Patients with HbA1c > 11%. ï?? Patients with acute macro vascular complications, cancer, pulmonary tuberculosis, and rheumatoid arthritis ï?? Patients who will be unable to perform yoga. ï?? Patients receiving drugs like drotaverine, beta-blockers or any other drug likely to affect autonomic function tests ï?? Patients with history of angina/uncontrolled hyperglycaemia/any other contraindication applied by American Diabetic Association (ADA).

Design outcomes

Primary

MeasureTime frame
effect of Yoga based intervention on Autonomic function in Type Two Diabetes Mellitus patients suffering from Autonomic NeuropathyTimepoint: baseline , 4 week, 8th week and 12th week

Secondary

MeasureTime frame
Change in dose of Oral hypoglycaemic agentsTimepoint: 4th week, 8th week and 12 week;Change in HbA1c, lipid profile, Nerve Conduction Velocity, Liver function test, Kidney function test, fasting blood sugar, Post prandial blood sugar, Random blood Sugar Change in HbA1c, lipid profile, Nerve Conduction Velocity, Liver function test, Kidney function test, fasting blood sugar, Post prandial blood sugar, Random blood Sugar Timepoint: 4th week, 8th week and 12th week

Countries

India

Contacts

Public ContactDr Puneet Dhamija

Aiims Rishikesh

drpdhamija@gmail.com8475000292

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026